Jump to content

Recurrent breast cancer

From Surgopaedia

Patterns

[edit | edit source]
  • Local recurrence
    • True recurrence - at lumpectomy site
    • Marginal miss - recurrence close to but not within the boost volume
    • Elsewhere recurrence - different quadrant to original procedure
  • Regional recurrence - draining lymph nodes - axillary, infraclavicular, supraclavicular, internal mammary
  • Metastatic disease

Predicting recurrence

[edit | edit source]
  • See entry under 'breast cancer'

Scenarios

[edit | edit source]
  • Ipsilateral breast tumour recurrence after breast-conserving therapy
    • Assuming metastasis has been excluded, mastectomy is standard of care. Repeat lumpectomy is associated with higher recurrence rates, especially if it's been <5 years since original cancer. If it's later than 5 years, likely to be a different primary cancer.
    • About 10-20% are inoperable for whatever reason
    • If regional spread is present, may need neoadjuvant CTX
    • Generally standard mastectomy with delayed reconstruction is necessary, due to previous radiation. Autologous tissue flaps (DIEP/TRAM) is often required.
    • Ability to perform nodal staging is dependent on original operation
  • Local recurrence after mastectomy
    • Uncommon
    • Assess feasibility of resection with examination, USS, MRI, CT - may require WLE of ribs or chest wall etc
    • Consider neoadjuvant CTX
  • Lymph node recurrence
    • Incidence is about 1% in those who had ALND, and less than that if they had a negative SLNB originally
    • Workup:
      • Full systemic staging (CT BCAP + bone scan/PET)
      • Core biopsy of axillary disease to confirm same molecular profile to original tumour
    • Treatment:
      • If they were previously SLNB negative or never had an ALND, they should have an ALND
      • If they already had an ALND, they should have a redo/completion ALND to level III, or radiotherapy to axilla
      • Adjuvant systemic therapy if not contraindicated
    • Prognosis: 60% overall survival at 5 years, 45% at 10 years